Plain-English translation of NCT04221893 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether radiation therapy can help immune therapy work better in patients with advanced cancers of the digestive system (esophagus, stomach, colon, pancreas, liver, and other GI organs) that have stopped responding to immune checkpoint inhibitor medications. The idea is that radiation therapy to some of the tumors might trigger the immune system to attack cancer throughout the body, not just the areas being radiated. Researchers will measure whether the treatment can slow or shrink the cancer and improve survival.
Many patients with advanced digestive cancers initially respond well to immune therapy, but eventually the cancer stops responding and starts growing again. This trial exists to see if combining radiation therapy with ongoing immune therapy can 'wake up' the immune system and help it fight back against cancer that has become resistant to the medication alone.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will receive 5 radiation therapy treatments over 5โ9 days to 1โ5 areas of your cancer while continuing your current immune therapy. Radiation therapy involves lying still on a table while a machine delivers focused beams of radiation to the tumor; each session typically takes 30โ60 minutes. After your treatments end, you will have follow-up visits at 2 weeks, 6 months, and then every few months for up to 3 years to check how you are doing and measure your response to the combined treatment.
AI-generated summary from trial data ยท Jun 12, 2026 ยท Not medical advice
United States